IA
MRK icon

Intellus Advisors’s Merck MRK Stock Holding History

Intellus Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$428K Sell
3,327
-77
-2% -$9.01K 0.05% 83
2026
Q1 		$409K Sell
3,404
-709
-17% -$81.9K 0.06% 81
2025
Q4 		$433K Buy
4,113
+332
+9% +$31.2K 0.06% 80
2025
Q3 		$317K Hold
3,781
– – 0.04% 102
2025
Q2 		$299K Buy
3,781
+192
+5% +$15.3K 0.04% 105
2025
Q1 		$322K Hold
3,589
– – 0.06% 92
2024
Q4 		$357K Buy
+3,589
New +$370K 0.06% 80

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Intellus Advisors's MRK Position: Q2 2026 in Review

Intellus Advisors reduced its Merck (MRK) stake by 2.3% in Q2 2026, selling an estimated $9.01K and leaving 3,327 shares worth $428K. The position accounts for 0.05% of the portfolio, ranked #83.

Intellus Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $433K in Q4 2025. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Intellus Advisors held 3,327 shares of Merck worth $428K as of Q2 2026.
  • Intellus Advisors sold 77 Merck shares in Q2 2026, an estimated $9.01K.
  • Merck made up 0.05% of Intellus Advisors's portfolio in Q2 2026, its #83 holding.
  • Intellus Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Intellus Advisors's Merck position peaked at $433K in Q4 2025.
  • 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Intellus Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.